跳至主要内容
临床试验/CTRI/2021/04/032735
CTRI/2021/04/032735已完成未知

An open label single arm clinical trial to evaluate the safety and efficacy of NEEMINT capsules in management of gastrointestinal disorders including irritable bowel syndrome.

TRA GRACE0 个研究点目标入组 15 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
15

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Subjects in the age group of 18-65 yrs (Inclusive of both genders).
  • 2.Subjects with 2 or more symptoms like indigestion ,abdominal pain or cramps, nausea ,vomiting, bloating, constipation, diarrhoea, changes in bowel habits, loss of appetite.
  • 3.Subjects/legal representative, willing to give a voluntary written informed consent.
  • 4.Subjects should not participate in any other clinical study during participation in the current study

排除标准

  • 1.Subjects with any cardiovascular, renal, respiratory or any other chronic illness.
  • 2.Pregnant or lactating females.
  • 3.Allergy to test product.
  • 4.Any subject, in the investigators opinion not considered suitable for enrollment.
  • 5.Subject participating in a similar clinical study, currently or during the previous 90 days

研究者

发起方
TRA GRACE

相似试验

A clinical trial to study the effectiveness and... | 临床试验